Written Question·Department of Health and Social Care·UIN 65266

Macular Degeneration: Drugs

Tabled: 7 July 2025

Answered: 14 July 2025

Question

Jim Shannon

To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential impact of making Apolipoprotein M available through the NHS on the prevention of macular degeneration.

Answer

Karin Smyth

The Department has not made an assessment. There are no approved medicinal products in the United Kingdom with apolipoprotein M, and there is no specifically approved product for macular degeneration that is known to act mainly by increasing apolipoprotei...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 65266) →